Global Non-Opioid Pain Treatment Market Size study, by Product (Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived), by Application (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Others) and Regional Forecasts 2020-2027
Global Non-Opioid Pain Treatment Market is valued at approximately USD 13.8 million in 2019 and is anticipated to grow with a healthy growth rate of more than 18% over the forecast period 2020-2027. Non-opioid pain treatment is the complementary to the opioids treatment which are increasingly used for the mild to moderate pain. Non opioids pain treatment is regularly taken with or without remedy that is over the counter (OTC) drugs. This treatment method are often robust pain relievers. They typically opt in the place of opioids due to its increase addiction triggered by opioids. For acute pain, non-opioid drugs are ideal to provide effective health benefits and first-line treatment and are available in over the counter and prescription formulations. This has led to a rise in demand for non-opioid treatment all over the world. Moreover, the increasing prevalence of chronic diseases such as cancer in the developed & developing countries, along with the rising research and developmental (R&D) efforts associated with non-opioid treatment for pain relief are few other factors responsible for the market growth over the forecast period. As per the International Agency for Research on Cancer (IARC), around 17.0 million new cancer cases were registered in 2018, with overall 9.5 million cancer deaths around the world. As per the IARC, the global prevalence of cancer is also expected to grow to over 27.5 million new cancer cases and 16.3 million cancer deaths by the year 2040. This, in turn, is expected to accelerate the demand for Non-Opioid Pain Treatment around the world. Recently, the COVID-19 is widely spread throughout the world, thus various regional governments are mandating the use of several drugs among the patients for disease management and/or to prevent the spread of COVID-19. This is likely to positively impact the growth of the non-opioid pain treatment drugs market. However, the presence for alternative therapies and counterfeit products is one of the major factors impeding the market growth over the forecast period of 2020-2027.
The regional analysis of the global Non-Opioid Pain Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the undergoing clinical trials and funding for R&D of novel drug therapies, along with the presence of significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence of chronic diseases, along with the changing economic demographic which improve drug affordability would create lucrative growth prospects for the Non-Opioid Pain Treatment market across the Asia-Pacific region.
Major market player included in this report are:
Medropharm Gmbh
US Worldmeds LLC
Centrexion Therapeutics Corp.
Tilray, Inc.
GW Pharmaceuticals, plc
Allergan plc
Cronos Group
Medical Marijuana, Inc.
Cara Therapeutics, Inc.
Canopy Growth Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Medical Cannabis
Menthol-Containing
Omega 3 Fatty Acid-Containing
Botulinum Toxins
Capsaicin-Derived
By Application:
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Non-Opioid Pain Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of the global Non-Opioid Pain Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the undergoing clinical trials and funding for R&D of novel drug therapies, along with the presence of significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence of chronic diseases, along with the changing economic demographic which improve drug affordability would create lucrative growth prospects for the Non-Opioid Pain Treatment market across the Asia-Pacific region.
Major market player included in this report are:
Medropharm Gmbh
US Worldmeds LLC
Centrexion Therapeutics Corp.
Tilray, Inc.
GW Pharmaceuticals, plc
Allergan plc
Cronos Group
Medical Marijuana, Inc.
Cara Therapeutics, Inc.
Canopy Growth Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Medical Cannabis
Menthol-Containing
Omega 3 Fatty Acid-Containing
Botulinum Toxins
Capsaicin-Derived
By Application:
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Non-Opioid Pain Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Non-Opioid Pain Treatment Market, by Region, 2018-2027 (USD Million)
1.2.2. Non-Opioid Pain Treatment Market, by Product, 2018-2027 (USD Million)
1.2.3. Non-Opioid Pain Treatment Market, by Application, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NON-OPIOID PAIN TREATMENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NON-OPIOID PAIN TREATMENT MARKET DYNAMICS
3.1. Non-Opioid Pain Treatment Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL NON-OPIOID PAIN TREATMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NON-OPIOID PAIN TREATMENT MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Non-Opioid Pain Treatment Market by Product, Performance - Potential Analysis
5.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Product 2017-2027 (USD Million)
5.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
5.4.1. Medical Cannabis
5.4.2. Menthol-Containing
5.4.3. Omega 3 Fatty Acid-Containing
5.4.4. Botulinum Toxins
5.4.5. Capsaicin-Derived
CHAPTER 6. GLOBAL NON-OPIOID PAIN TREATMENT MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Non-Opioid Pain Treatment Market by Application, Performance - Potential Analysis
6.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Application 2017-2027 (USD Million)
6.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
6.4.1. Orthopaedic and Musculoskeletal Pain
6.4.2. Neuropathic Pain
6.4.3. Cancer Pain
6.4.4. Others
CHAPTER 7. GLOBAL NON-OPIOID PAIN TREATMENT MARKET, REGIONAL ANALYSIS
7.1. Non-Opioid Pain Treatment Market, Regional Market Snapshot
7.2. North America Non-Opioid Pain Treatment Market
7.2.1. U.S. Non-Opioid Pain Treatment Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Non-Opioid Pain Treatment Market
7.3. Europe Non-Opioid Pain Treatment Market Snapshot
7.3.1. U.K. Non-Opioid Pain Treatment Market
7.3.2. Germany Non-Opioid Pain Treatment Market
7.3.3. France Non-Opioid Pain Treatment Market
7.3.4. Spain Non-Opioid Pain Treatment Market
7.3.5. Italy Non-Opioid Pain Treatment Market
7.3.6. Rest of Europe Non-Opioid Pain Treatment Market
7.4. Asia-Pacific Non-Opioid Pain Treatment Market Snapshot
7.4.1. China Non-Opioid Pain Treatment Market
7.4.2. India Non-Opioid Pain Treatment Market
7.4.3. Japan Non-Opioid Pain Treatment Market
7.4.4. Australia Non-Opioid Pain Treatment Market
7.4.5. South Korea Non-Opioid Pain Treatment Market
7.4.6. Rest of Asia Pacific Non-Opioid Pain Treatment Market
7.5. Latin America Non-Opioid Pain Treatment Market Snapshot
7.5.1. Brazil Non-Opioid Pain Treatment Market
7.5.2. Mexico Non-Opioid Pain Treatment Market
7.6. Rest of The World Non-Opioid Pain Treatment Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Medropharm Gmbh
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. US Worldmeds LLC
8.2.3. Centrexion Therapeutics Corp.
8.2.4. Tilray, Inc.
8.2.5. GW Pharmaceuticals, plc
8.2.6. Allergan plc
8.2.7. Cronos Group
8.2.8. Medical Marijuana, Inc.
8.2.9. Cara Therapeutics, Inc.
8.2.10. Canopy Growth Corporation
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Non-Opioid Pain Treatment Market, by Region, 2018-2027 (USD Million)
1.2.2. Non-Opioid Pain Treatment Market, by Product, 2018-2027 (USD Million)
1.2.3. Non-Opioid Pain Treatment Market, by Application, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NON-OPIOID PAIN TREATMENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NON-OPIOID PAIN TREATMENT MARKET DYNAMICS
3.1. Non-Opioid Pain Treatment Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL NON-OPIOID PAIN TREATMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NON-OPIOID PAIN TREATMENT MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Non-Opioid Pain Treatment Market by Product, Performance - Potential Analysis
5.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Product 2017-2027 (USD Million)
5.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
5.4.1. Medical Cannabis
5.4.2. Menthol-Containing
5.4.3. Omega 3 Fatty Acid-Containing
5.4.4. Botulinum Toxins
5.4.5. Capsaicin-Derived
CHAPTER 6. GLOBAL NON-OPIOID PAIN TREATMENT MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Non-Opioid Pain Treatment Market by Application, Performance - Potential Analysis
6.3. Global Non-Opioid Pain Treatment Market Estimates & Forecasts by Application 2017-2027 (USD Million)
6.4. Non-Opioid Pain Treatment Market, Sub Segment Analysis
6.4.1. Orthopaedic and Musculoskeletal Pain
6.4.2. Neuropathic Pain
6.4.3. Cancer Pain
6.4.4. Others
CHAPTER 7. GLOBAL NON-OPIOID PAIN TREATMENT MARKET, REGIONAL ANALYSIS
7.1. Non-Opioid Pain Treatment Market, Regional Market Snapshot
7.2. North America Non-Opioid Pain Treatment Market
7.2.1. U.S. Non-Opioid Pain Treatment Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Non-Opioid Pain Treatment Market
7.3. Europe Non-Opioid Pain Treatment Market Snapshot
7.3.1. U.K. Non-Opioid Pain Treatment Market
7.3.2. Germany Non-Opioid Pain Treatment Market
7.3.3. France Non-Opioid Pain Treatment Market
7.3.4. Spain Non-Opioid Pain Treatment Market
7.3.5. Italy Non-Opioid Pain Treatment Market
7.3.6. Rest of Europe Non-Opioid Pain Treatment Market
7.4. Asia-Pacific Non-Opioid Pain Treatment Market Snapshot
7.4.1. China Non-Opioid Pain Treatment Market
7.4.2. India Non-Opioid Pain Treatment Market
7.4.3. Japan Non-Opioid Pain Treatment Market
7.4.4. Australia Non-Opioid Pain Treatment Market
7.4.5. South Korea Non-Opioid Pain Treatment Market
7.4.6. Rest of Asia Pacific Non-Opioid Pain Treatment Market
7.5. Latin America Non-Opioid Pain Treatment Market Snapshot
7.5.1. Brazil Non-Opioid Pain Treatment Market
7.5.2. Mexico Non-Opioid Pain Treatment Market
7.6. Rest of The World Non-Opioid Pain Treatment Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Medropharm Gmbh
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. US Worldmeds LLC
8.2.3. Centrexion Therapeutics Corp.
8.2.4. Tilray, Inc.
8.2.5. GW Pharmaceuticals, plc
8.2.6. Allergan plc
8.2.7. Cronos Group
8.2.8. Medical Marijuana, Inc.
8.2.9. Cara Therapeutics, Inc.
8.2.10. Canopy Growth Corporation
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Non-Opioid Pain Treatment market, report scope
TABLE 2. Global Non-Opioid Pain Treatment market estimates & forecasts by region 2017-2027 (USD Million)
TABLE 3. Global Non-Opioid Pain Treatment market estimates & forecasts by Product 2017-2027 (USD Million)
TABLE 4. Global Non-Opioid Pain Treatment market estimates & forecasts by Application 2017-2027 (USD Million)
TABLE 5. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 6. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 7. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 8. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 9. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 10. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 11. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 12. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 13. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 14. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 15. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 16. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 17. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 18. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 19. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 20. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 21. U.S. Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 22. U.S. Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 23. U.S. Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 24. Canada Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 25. Canada Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 26. Canada Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 27. UK Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 28. UK Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 29. UK Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 30. Germany Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 31. Germany Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 32. Germany Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 33. France Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 34. France Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 35. France Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 36. Spain Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 37. Spain Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 38. Spain Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 39. Italy Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 40. Italy Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 41. Italy Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 42. ROE Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 43. ROE Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 44. ROE Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 45. China Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 46. China Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 47. China Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 48. India Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 49. India Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 50. India Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 51. Japan Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 52. Japan Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 53. Japan Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 54. Australia Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 55. Australia Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 56. Australia Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 57. South Korea Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 58. South Korea Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 59. South Korea Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 60. ROPAC Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 61. ROPAC Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 62. ROPAC Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 63. Brazil Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 64. Brazil Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 65. Brazil Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 66. Mexico Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 67. Mexico Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 68. Mexico Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 69. ROLA Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 70. ROLA Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 71. ROLA Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 72. ROW Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 73. ROW Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 74. ROW Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 75. List of secondary sources, used in the study of global Non-Opioid Pain Treatment market
TABLE 76. List of primary sources, used in the study of global Non-Opioid Pain Treatment market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered
TABLE 1. Global Non-Opioid Pain Treatment market, report scope
TABLE 2. Global Non-Opioid Pain Treatment market estimates & forecasts by region 2017-2027 (USD Million)
TABLE 3. Global Non-Opioid Pain Treatment market estimates & forecasts by Product 2017-2027 (USD Million)
TABLE 4. Global Non-Opioid Pain Treatment market estimates & forecasts by Application 2017-2027 (USD Million)
TABLE 5. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 6. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 7. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 8. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 9. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 10. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 11. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 12. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 13. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 14. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 15. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 16. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 17. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 18. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 19. Global Non-Opioid Pain Treatment market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 20. Global Non-Opioid Pain Treatment market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 21. U.S. Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 22. U.S. Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 23. U.S. Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 24. Canada Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 25. Canada Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 26. Canada Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 27. UK Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 28. UK Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 29. UK Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 30. Germany Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 31. Germany Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 32. Germany Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 33. France Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 34. France Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 35. France Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 36. Spain Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 37. Spain Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 38. Spain Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 39. Italy Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 40. Italy Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 41. Italy Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 42. ROE Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 43. ROE Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 44. ROE Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 45. China Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 46. China Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 47. China Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 48. India Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 49. India Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 50. India Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 51. Japan Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 52. Japan Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 53. Japan Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 54. Australia Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 55. Australia Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 56. Australia Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 57. South Korea Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 58. South Korea Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 59. South Korea Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 60. ROPAC Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 61. ROPAC Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 62. ROPAC Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 63. Brazil Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 64. Brazil Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 65. Brazil Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 66. Mexico Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 67. Mexico Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 68. Mexico Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 69. ROLA Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 70. ROLA Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 71. ROLA Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 72. ROW Non-Opioid Pain Treatment market estimates & forecasts, 2017-2027 (USD Million)
TABLE 73. ROW Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 74. ROW Non-Opioid Pain Treatment market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 75. List of secondary sources, used in the study of global Non-Opioid Pain Treatment market
TABLE 76. List of primary sources, used in the study of global Non-Opioid Pain Treatment market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Non-Opioid Pain Treatment market, research methodology
FIG 2. Global Non-Opioid Pain Treatment market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Non-Opioid Pain Treatment market, key trends 2019
FIG 5. Global Non-Opioid Pain Treatment market, growth prospects 2020-2027
FIG 6. Global Non-Opioid Pain Treatment market, porters 5 force model
FIG 7. Global Non-Opioid Pain Treatment market, pest analysis
FIG 8. Global Non-Opioid Pain Treatment market, value chain analysis
FIG 9. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 10. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 11. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 12. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 13. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 14. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 15. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 16. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 17. Global Non-Opioid Pain Treatment market, regional snapshot 2017 & 2027
FIG 18. North America Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 19. Europe Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 20. Asia-Pacific Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 21. Latin America Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 22. Global Non-Opioid Pain Treatment market, company market share analysis (2019)
COMPANIES MENTIONED
Medropharm Gmbh
US Worldmeds LLC
Centrexion Therapeutics Corp.
Tilray, Inc.
GW Pharmaceuticals, plc
Allergan plc
Cronos Group
Medical Marijuana, Inc.
Cara Therapeutics, Inc.
Canopy Growth Corporation
FIG 1. Global Non-Opioid Pain Treatment market, research methodology
FIG 2. Global Non-Opioid Pain Treatment market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Non-Opioid Pain Treatment market, key trends 2019
FIG 5. Global Non-Opioid Pain Treatment market, growth prospects 2020-2027
FIG 6. Global Non-Opioid Pain Treatment market, porters 5 force model
FIG 7. Global Non-Opioid Pain Treatment market, pest analysis
FIG 8. Global Non-Opioid Pain Treatment market, value chain analysis
FIG 9. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 10. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 11. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 12. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 13. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 14. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 15. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 16. Global Non-Opioid Pain Treatment market by segment, 2017 & 2027 (USD Million)
FIG 17. Global Non-Opioid Pain Treatment market, regional snapshot 2017 & 2027
FIG 18. North America Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 19. Europe Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 20. Asia-Pacific Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 21. Latin America Non-Opioid Pain Treatment market 2017 & 2027 (USD Million)
FIG 22. Global Non-Opioid Pain Treatment market, company market share analysis (2019)
COMPANIES MENTIONED
Medropharm Gmbh
US Worldmeds LLC
Centrexion Therapeutics Corp.
Tilray, Inc.
GW Pharmaceuticals, plc
Allergan plc
Cronos Group
Medical Marijuana, Inc.
Cara Therapeutics, Inc.
Canopy Growth Corporation
